The global human papillomavirus protein E6 market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of HPV-related cancers and rising awareness about HPV infection. The cervical intraepithelial neoplasia segment is expected to dominate the global human papillomavirus protein E6 market during the forecast period, owing to its high prevalence in women and its association with cervical cancer.
The global human papillomavirus protein E6 market by type includes AB301, BVAC, ETB041, G188E. AB301 segment is expected to lead the global human papillomavirus protein E6 market by type during the forecast period due to its high efficacy against cervical intraepithelial neoplasia (CIN) 2/3 lesions in women with normal cytology and low risk for progression into invasive cancer.
Some Of The Growth Factors Of This Market:
- The Human Papillomavirus Protein E6 market is driven by the increasing prevalence of HPV infection and its association with cervical cancer, which has led to an increase in demand for HPV vaccines and treatment options.
- Increasing awareness about HPV infection and its association with cervical cancer has led to increased demand for HPV vaccines and treatment options, which are driving the growth of the Human Papillomavirus Protein E6 market.
- The Human Papillomavirus Protein E6 market is also driven by increasing number of women who are getting screened for cervical cancer due to increased awareness about this disease.
- Increasing incidence rates of cervical cancer in developing countries such as India, China, Brazil, Mexico etc, will drive the growth of this market.
Industry Growth Insights published a new data on “Human Papillomavirus Protein E6 Market”. The research report is titled “Human Papillomavirus Protein E6 Market research by Types (ABN-301, BVAC-C, ETBX-041, GX-188E, Others), By Applications (Cervical Intraepithelial Neoplasia, Lung Cancer, Oropharyngeal Cancer, Others), By Players/Companies Rottapharm Biotech Srl, Selecta Biosciences Inc, Transgene SA, Abion Inc, BioNTech AG, Cancer Research Technology Ltd, Etubics Corp, Genexine Inc, Hookipa Biotech AG, Inovio Pharmaceuticals Inc, MedImmune LLC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Papillomavirus Protein E6 Market Research Report
By Type
ABN-301, BVAC-C, ETBX-041, GX-188E, Others
By Application
Cervical Intraepithelial Neoplasia, Lung Cancer, Oropharyngeal Cancer, Others
By Companies
Rottapharm Biotech Srl, Selecta Biosciences Inc, Transgene SA, Abion Inc, BioNTech AG, Cancer Research Technology Ltd, Etubics Corp, Genexine Inc, Hookipa Biotech AG, Inovio Pharmaceuticals Inc, MedImmune LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Human Papillomavirus Protein E6 Market Report Segments:
The global Human Papillomavirus Protein E6 market is segmented on the basis of:
Types
ABN-301, BVAC-C, ETBX-041, GX-188E, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cervical Intraepithelial Neoplasia, Lung Cancer, Oropharyngeal Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Rottapharm Biotech Srl
- Selecta Biosciences Inc
- Transgene SA
- Abion Inc
- BioNTech AG
- Cancer Research Technology Ltd
- Etubics Corp
- Genexine Inc
- Hookipa Biotech AG
- Inovio Pharmaceuticals Inc
- MedImmune LLC
Highlights of The Human Papillomavirus Protein E6 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ABN-301
- BVAC-C
- ETBX-041
- GX-188E
- Others
- By Application:
- Cervical Intraepithelial Neoplasia
- Lung Cancer
- Oropharyngeal Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Papillomavirus Protein E6 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human Papillomavirus Protein E6 is a protein that helps the virus attach to cells.
Some of the key players operating in the human papillomavirus protein e6 market are Rottapharm Biotech Srl, Selecta Biosciences Inc, Transgene SA, Abion Inc, BioNTech AG, Cancer Research Technology Ltd, Etubics Corp, Genexine Inc, Hookipa Biotech AG, Inovio Pharmaceuticals Inc, MedImmune LLC.
The human papillomavirus protein e6 market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Papillomavirus Protein E6 Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Papillomavirus Protein E6 Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Papillomavirus Protein E6 Market - Supply Chain
4.5. Global Human Papillomavirus Protein E6 Market Forecast
4.5.1. Human Papillomavirus Protein E6 Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Papillomavirus Protein E6 Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Papillomavirus Protein E6 Market Absolute $ Opportunity
5. Global Human Papillomavirus Protein E6 Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Papillomavirus Protein E6 Market Size and Volume Forecast by Type
5.3.1. ABN-301
5.3.2. BVAC-C
5.3.3. ETBX-041
5.3.4. GX-188E
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Papillomavirus Protein E6 Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Papillomavirus Protein E6 Market Size and Volume Forecast by Application
6.3.1. Cervical Intraepithelial Neoplasia
6.3.2. Lung Cancer
6.3.3. Oropharyngeal Cancer
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Papillomavirus Protein E6 Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Papillomavirus Protein E6 Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Papillomavirus Protein E6 Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Papillomavirus Protein E6 Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Papillomavirus Protein E6 Demand Share Forecast, 2019-2029
9. North America Human Papillomavirus Protein E6 Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Papillomavirus Protein E6 Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Papillomavirus Protein E6 Market Size and Volume Forecast by Application
9.4.1. Cervical Intraepithelial Neoplasia
9.4.2. Lung Cancer
9.4.3. Oropharyngeal Cancer
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Papillomavirus Protein E6 Market Size and Volume Forecast by Type
9.7.1. ABN-301
9.7.2. BVAC-C
9.7.3. ETBX-041
9.7.4. GX-188E
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Papillomavirus Protein E6 Demand Share Forecast, 2019-2029
10. Latin America Human Papillomavirus Protein E6 Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Papillomavirus Protein E6 Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Papillomavirus Protein E6 Market Size and Volume Forecast by Application
10.4.1. Cervical Intraepithelial Neoplasia
10.4.2. Lung Cancer
10.4.3. Oropharyngeal Cancer
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Papillomavirus Protein E6 Market Size and Volume Forecast by Type
10.7.1. ABN-301
10.7.2. BVAC-C
10.7.3. ETBX-041
10.7.4. GX-188E
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Papillomavirus Protein E6 Demand Share Forecast, 2019-2029
11. Europe Human Papillomavirus Protein E6 Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Papillomavirus Protein E6 Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Papillomavirus Protein E6 Market Size and Volume Forecast by Application
11.4.1. Cervical Intraepithelial Neoplasia
11.4.2. Lung Cancer
11.4.3. Oropharyngeal Cancer
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Papillomavirus Protein E6 Market Size and Volume Forecast by Type
11.7.1. ABN-301
11.7.2. BVAC-C
11.7.3. ETBX-041
11.7.4. GX-188E
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Papillomavirus Protein E6 Demand Share, 2019-2029
12. Asia Pacific Human Papillomavirus Protein E6 Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Papillomavirus Protein E6 Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Papillomavirus Protein E6 Market Size and Volume Forecast by Application
12.4.1. Cervical Intraepithelial Neoplasia
12.4.2. Lung Cancer
12.4.3. Oropharyngeal Cancer
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Papillomavirus Protein E6 Market Size and Volume Forecast by Type
12.7.1. ABN-301
12.7.2. BVAC-C
12.7.3. ETBX-041
12.7.4. GX-188E
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Papillomavirus Protein E6 Demand Share, 2019-2029
13. Middle East & Africa Human Papillomavirus Protein E6 Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Papillomavirus Protein E6 Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Papillomavirus Protein E6 Market Size and Volume Forecast by Application
13.4.1. Cervical Intraepithelial Neoplasia
13.4.2. Lung Cancer
13.4.3. Oropharyngeal Cancer
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Papillomavirus Protein E6 Market Size and Volume Forecast by Type
13.7.1. ABN-301
13.7.2. BVAC-C
13.7.3. ETBX-041
13.7.4. GX-188E
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Papillomavirus Protein E6 Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Human Papillomavirus Protein E6 Market: Market Share Analysis
14.2. Human Papillomavirus Protein E6 Distributors and Customers
14.3. Human Papillomavirus Protein E6 Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Rottapharm Biotech Srl
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Selecta Biosciences Inc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Transgene SA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abion Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BioNTech AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cancer Research Technology Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Etubics Corp
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Genexine Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Hookipa Biotech AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Inovio Pharmaceuticals Inc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MedImmune LLC
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
